PDK4 and diffuse large B-cell lymphoma: Initially, tumor tissues from DLBCL patients sensitive and resistant to rituximab chemotherapy were collected, and the expression and cellular localization of PDK4 in resistant tumor tissues were explored through immunohistochemistry.